0
There is no goods in the shopping cart !
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 0-9
Your Position: Home > BAFFR

BAFFR

BAFFR Molecule Information

Name:B-cell activating factor receptor
Target Synonym:BAFF-R;TNFRSF13C;BAFFR;BR3;B-cell-activating factor receptor;BAFF receptor;BLyS receptor 3;CD268
Number of Launched Drugs:0
Number of Drugs in Clinical Trials:2
Lastest Research Phase:Phase ?

BAFFR Protein Product ListCompare or Buy

BAFFR Part of Bioactivity data

BAR-H5258-SPR
Human_FcRn_Heterodimer_Protein_SPR

Immobilized Human BAFF, Fc Tag, active trimer (Cat. No. BAF-H5261) captured on CM5 chip via Anti-human IgG Fc antibodies surface can bind Human BAFFR, Llama IgG2b Fc Tag, low endotoxin (Cat. No. BAR-H5258) with an affinity constant of 44.5 nM as determined in a SPR assay (Biacore T200) (Routinely tested).

BAR-H5257-SPR
Human_FcRn_Heterodimer_Protein_SPR

Immobilized Biotinylated Human BAFF, Avitag,Fc Tag (active trimer) (MALS verified) (Cat. No. BAF-H82F3) on SA Chip can bind Human BAFFR, Fc Tag (Cat. No. BAR-H5257) with an affinity constant of 26.7 nM as determined in a SPR assay (Biacore T200) (Routinely tested).

BAFFR Molecule Synonym Name

BAFFR,TNFRSF13C,BROMIX,CD268,CVID4,prolixin,BAFF-R

BAFFR Molecule Background

BAFF receptor (B-cell activating factor receptor, BAFF-R), also known as tumor necrosis factor receptor superfamily member 13C (TNFRSF13C), is a membrane protein of the TNF receptor superfamily which recognizes BAFF. B-cell activating factor (BAFF) enhances B-cell survival in vitro and is a regulator of the peripheral B-cell population. Overexpression of BAFF in mice results in mature B-cell hyperplasia and symptoms of systemic lupus erythematosus (SLE). Also, some SLE patients have increased levels of BAFF in serum. Therefore, it has been proposed that abnormally high levels of BAFF may contribute to the pathogenesis of autoimmune diseases by enhancing the survival of autoreactive B cells.

BAFFR References

BAFFR Related Molecule

BAFFR Clinical Drug Information

Name Research Code Research Phase Company Indications Clinical Trials
Briobacept Phase Ⅱ Biogen Idec, Genentech Chronic lymphocytic leukemia (CLL), Sjoegren's syndrome, Rheumatoid arthritis (RA) Details
Ianalumab NOV-5; VAY-736 Phase Ⅲ MorphoSys, Novartis Autoimmune hepatitis Details

This web search service is supported by Google Inc.

totop